News for BrightPath Biotherapeutics Co., Ltd. (4594.T)

The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...

/PRNewswire/ -- The vaccine market is expected to grow by USD 28.28 billion from 2021 to 2026. In addition, the momentum of the market will progress at a CAGR...

The global cell therapy market is predicted to showcase positive growth owing to the rising incidence of oncological disorders such as blood cancer and...

/PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Neoantigen Cancer Vaccine Market was valued at more than USD 1.8 billion...

/PRNewswire/ -- The global vaccines market is expected to grow by USD 28.28 billion, accelerating at a CAGR of 4.13% between 2021 to 2026, according to...

/PRNewswire/ -- The

/PRNewswire/ -- The vaccine market size is set to grow by USD 28.28 billion from 2021 to 2026, progressing at a CAGR of 4.13% according to the latest forecast...